Latest Headlines

  1. HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics 4/7/2026

    HNL Lab Medicine today announced a preferred partnership with Roche Diagnostics.

  2. PathAI And MedStar Health Announce Partnership To Deploy The AISight® Dx Digital Pathology Platform And Advanced AI Applications 4/7/2026

    PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic collaboration to deploy PathAI’s AISight® Dx1 Digital Pathology Platform and various AI algorithm products across the multi-site network.

  3. Plus Therapeutics Receives AMA PLA Code For CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement And U.S. Commercial Adoption 4/7/2026

    Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that the American Medical Association (AMA) has approved a new, Proprietary Laboratory Analyses (PLA) Current Procedural Terminology (CPT) code for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) test.

  4. Unique Tube Technology Enhances Sample Management Workflows 4/7/2026

    Azenta Life Sciences reports how its unique Acoustic tube technology is enabling fully acoustic workflows promoting faster, more efficient sample management in next-generation compound management and screening workflows.

  5. UCLA Researchers Develop Low-Cost Blood Test To Detect Multiple Cancers And Other Diseases From A Single Sample 4/6/2026

    UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities simultaneously by analyzing DNA fragments circulating in the bloodstream.

  6. Blood Test Using Artificial Intelligence Paves The Way For Early Diagnosis Of Leprosy 4/6/2026

    A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. Researchers at the University of São Paulo (USP) tested the new test in Brazil using blood samples collected during a COVID-19 population survey.

  7. GeneProof Announces CMV IVDR Launch On The myCROBE™ Fully Automated System For Transplant Care 4/2/2026

    GeneProof, a molecular diagnostics manufacturer and part of NuvinkaDx, announced several significant product and regulatory milestones.

  8. Cancer Is Striking Earlier - Superpower And GRAIL Are Partnering To Expand Early Detection 4/1/2026

    Superpower, the first all-in-one proactive health platform, announced a strategic partnership with GRAIL, Inc. (Nasdaq: GRAL) to bring members access to the Galleri® multi-cancer early detection (MCED) test.

  9. Breaking The PCR-Only Barrier: Dual 510(k) Clearance And CLIA-Waiver Establish FINDER As The First Molecular Point-Of-Care Platform With Multifunctional Capabilities 3/31/2026

    Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the FINDER® Flu A&B/SARS-CoV-2 Test, an ultra-rapid RT-PCR assay on the FINDER platform.

  10. Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM 3/31/2026

    Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before.